#GPFUQ 177 What’s
wrong with the regulators?
A paradox of the new regulation of professionals like GMC Revalidation and the Care Quality Commission (CQC) that aims to reduce
unacceptable variations in their performance is that the regulation itself can
create unacceptable variations in regulation with poor quality assurance of both the structure and
process of regulation creating variable outcomes.
#GPFUQ 178
When is it the best treatment to stop medicines?
If it improves patient outcomes. Risk can outweigh benefit when too many
medicines are prescribed in patients with too many co-morbidties. Reducing and stopping
drugs can then become the best treatment. There are 5 steps (1) check all drugs the patient is taking and the
reasons for each one; (2)
consider the overall risk of drug-induced harm in individual patients before
a deprescribing intervention; (3) assess
each drug in regard to its current or future benefit potential compared with
current or future harm or burden potential; (4) prioritize and agree with the
patient the drugs for discontinuation that have the lowest benefit-harm ratio
and lowest likelihood of adverse withdrawal reactions or disease rebound
syndromes; and (5) implement a discontinuation regimen and monitor patient for improvement in outcomes or onset of
adverse effects.
#GPFUQ 179 What’s the problem recording shared-decision
making (SDM)? The use of electronic templates to gather data for whatever
reason has shifted consultations from being patient-centred to
computer-centred. The paradox is that the more time we spend recording SDM, the
less time we have to actually do it.
#GPFUQ
180 When shouldn’t we ask for extra money for health care? If we are already
spending money doing something pointless, or if
we are looking for technical solutions to existential problems.
No comments:
Post a Comment